Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

RCVS should be considered in thunderclap headaches, and MRA and DSA are better for diagnosis than CT angiogram.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The combination therapy effectively improved acne keloidalis nuchae.

JAK inhibitors show promise in treating difficult skin diseases.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Temporal triangular alopecia is a non-scarring hair loss seen in some Asian children.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

A 10-year-old boy had the earliest reported case of hair that became progressively kinkier but eventually returned to normal on its own.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

Tofacitinib helped a woman regrow hair with no major side effects.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

AI can effectively predict COVID-19 mortality risk using patient data.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Orf infections can happen during the Muslim event 'Aid el Kebir' due to close contact with sheep.